Fosun International : First Patient Dosed of Phase 2 Clinical Trial of Serplulimab in Combination with Innovative Anti-LAG-3 mAb for the Treatment of Metastatic Colorectal Cancer Patients
First Patient Dosed of Phase 2 Clinical Trial of Serplulimab in Combination with Innovative Anti-LAG-3 mAb for the Treatment of Metastatic Colorectal Cancer Patients ... | June 16, 2023
United States Yi Nan United Kingdom Norihiro Kokudoc Gunnar Folprechtd Robertp Jonesa Shanghai Henlius Biotech Inc
Source: marketscreener.com